GGrantIndex
← Search

Developmental Funds

$587,452P30FY2023CANIH

Wake Forest University Health Sciences, Winston-Salem NC

Investigators

Linked publications, trials & patents

Trial NCT07614022Trial NCT07324577Trial NCT07322367Trial NCT07282444Trial NCT07203534Trial NCT07196241Trial NCT07175376Trial NCT07119489Trial NCT07046936Trial NCT06945042Trial NCT06709404Trial NCT06654245Trial NCT06480591Trial NCT06441266Trial NCT06340503Trial NCT05984680Trial NCT05934851Trial NCT05877404Trial NCT05854966Trial NCT05825066Trial NCT05796518Trial NCT05696782Trial NCT05692635Trial NCT05597878Trial NCT05395936Trial NCT05309655Trial NCT05242770Trial NCT05212272Trial NCT05204290Trial NCT05030038Trial NCT04897217Trial NCT04858269Trial NCT04797884Trial NCT04677816Trial NCT04659993Trial NCT04623515Trial NCT04586127Trial NCT04526080Trial NCT04495751Trial NCT04485026Trial NCT04454489Trial NCT04430335Trial NCT04415944Trial NCT04375384Trial NCT04337580Trial NCT04327700Trial NCT04266470Trial NCT04253964Trial NCT04217317Trial NCT04174742Trial NCT04173247Trial NCT04111107Trial NCT04040244Trial NCT04037527Trial NCT03998189Trial NCT03987568Trial NCT03987555Trial NCT03982537Trial NCT03963739Trial NCT03958747Trial NCT03929211Trial NCT03890614Trial NCT03880526Trial NCT03874065Trial NCT03870529Trial NCT03870451Trial NCT03868943Trial NCT03867175Trial NCT03861091Trial NCT03861065Trial NCT03796273Trial NCT03746262Trial NCT03741868Trial NCT03741829Trial NCT03740035Trial NCT03681405Trial NCT03662074Trial NCT03529565Trial NCT03520283Trial NCT03505762Trial NCT03505736Trial NCT03505671Trial NCT03379376Trial NCT03374995Trial NCT03370159Trial NCT03188432Trial NCT03152786Trial NCT03148080Trial NCT03139435Trial NCT03122743Trial NCT03087591Trial NCT03032250Trial NCT02971410Trial NCT02971397Trial NCT02949843Trial NCT02835222Trial NCT02835066Trial NCT02832154Trial NCT02827838Trial NCT02747407

Abstract

DEVELOPMENTAL FUNDS: PROJECT SUMMARY The Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) utilizes the Cancer Center Support Grant (CCSG) developmental funds to invest in specific efforts that support the research goals of its overall Strategic Plan. During the current project period, a total of $903,200 of CCSG developmental funds was distributed for pilot funding in support of 27 research projects, and to date these investments have already yielded a $16.6M (18-fold) return on investment. More importantly, the WFBCCC leadership leveraged the CCSG developmental funds with other Center resources during the project period, and in total it invested $3.4M in pilot awards during the project period (minus the awards made in late 2020). This investment can be directly linked to the successful award of $37.9M in extramural, multi-year grant funding – more than an 11-fold yield from the combined investment. In the next project period, the WFBCCC is requesting developmental funds to support pilot projects, and up to 20% effort for two early-stage clinical investigators annually who will be charged with developing and launching an innovative investigator-initiated trial and maximizing WFBCCC’s participation in the National Cancer Institute’s National Clinical Trials Network.

View original record on NIH RePORTER →
Developmental Funds · GrantIndex